Medicines Control Council threatens to de-register Nevirapine

Updated: 30 Sep 2019

Medicines Control Council threatens to de-register Nevirapine

The Medicines Control Council (MCC) threatens to de-register Nevirapine unless further studies and appropriate documentation can show its efficacy in the prevention of mother to child transmission of HIV .Glenda Grey of the perinatal HIV Research Unit at Chris Hani Baragwanath Hospital argues that enough evidence has already been presented, which suggest that Nevirapine with supplement does contain the mother to child transmission.

How we know this

01Health Systems Trust Nevirapine, Aids drug could be banned [online] Available at: www.hst.org.za [Accessed on 26 August 2013]
02All Africa South Africa: De-registration of Nevirapine unlikely:TAC [online] Available at: https://allafrica.com [Accessed on 26 August 2013]

Last updated · 30 Sep 2019

Cite this entry

South African History Online. (2011, March 16). Medicines Control Council threatens to de-register Nevirapine. South African History Online. https://sahistory.org.za/ref/E-0013527

South African History Online (2011) 'Medicines Control Council threatens to de-register Nevirapine', South African History Online, 16 March. Available at: https://sahistory.org.za/ref/E-0013527 (Accessed: 30 October 2026).

South African History Online, Medicines Control Council threatens to de-register Nevirapine [website], https://sahistory.org.za/ref/E-0013527, (accessed 30 October 2026).

"Medicines Control Council threatens to de-register Nevirapine." South African History Online, 16 Mar. 2011, https://sahistory.org.za/ref/E-0013527. Accessed 30 Oct. 2026.

South African History Online. "Medicines Control Council threatens to de-register Nevirapine." South African History Online. March 16, 2011. https://sahistory.org.za/ref/E-0013527.